Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Accenture
Express Scripts
Johnson and Johnson
AstraZeneca
Colorcon
McKesson
Harvard Business School
Argus Health

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202931

« Back to Dashboard

NDA 202931 describes FROVATRIPTAN SUCCINATE, which is a drug marketed by Glenmark Pharms Ltd and Mylan Pharms Inc and is included in two NDAs. It is available from two suppliers. Additional details are available on the FROVATRIPTAN SUCCINATE profile page.

The generic ingredient in FROVATRIPTAN SUCCINATE is frovatriptan succinate. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the frovatriptan succinate profile page.
Summary for 202931
Tradename:FROVATRIPTAN SUCCINATE
Applicant:Mylan Pharms Inc
Ingredient:frovatriptan succinate
Patents:0
Therapeutic Class:Antimigraine Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 202931
Suppliers and Packaging for NDA: 202931
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 202931 ANDA Mylan Pharmaceuticals Inc. 0378-3140 N 0378-3140-85

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 2.5MG BASE
Approval Date:Aug 28, 2014TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Cantor Fitzgerald
Covington
Baxter
Harvard Business School
Cerilliant
Daiichi Sankyo
UBS
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.